Relief Therapeutics Holding Stock Market Value
| RLFTY Stock | USD 4.80 0.20 4.00% |
| Symbol | Relief |
Relief Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Relief Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Relief Therapeutics.
| 11/20/2024 |
| 12/20/2024 |
If you would invest 0.00 in Relief Therapeutics on November 20, 2024 and sell it all today you would earn a total of 0.00 from holding Relief Therapeutics Holding or generate 0.0% return on investment in Relief Therapeutics over 30 days. Relief Therapeutics is related to or competes with NRX Pharmaceuticals, Pasithea Therapeutics, SAB Biotherapeutics, Biomx, Lexaria Bioscience, and Aditxt. Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious dise... More
Relief Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Relief Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Relief Therapeutics Holding upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.41 | |||
| Information Ratio | 0.1305 | |||
| Maximum Drawdown | 65.15 | |||
| Value At Risk | (15.07) | |||
| Potential Upside | 17.05 |
Relief Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Relief Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Relief Therapeutics' standard deviation. In reality, there are many statistical measures that can use Relief Therapeutics historical prices to predict the future Relief Therapeutics' volatility.| Risk Adjusted Performance | 0.1154 | |||
| Jensen Alpha | 1.39 | |||
| Total Risk Alpha | 1.1 | |||
| Sortino Ratio | 0.1471 | |||
| Treynor Ratio | 1.49 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Relief Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Relief Therapeutics Backtested Returns
Relief Therapeutics is very risky given 3 months investment horizon. Relief Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.14, which implies the firm had a 0.14% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.49% are justified by taking the suggested risk. Use Relief Therapeutics Semi Deviation of 6.38, coefficient of variation of 748.02, and Risk Adjusted Performance of 0.1154 to evaluate company specific risk that cannot be diversified away. Relief Therapeutics holds a performance score of 10 on a scale of zero to a hundred. The company holds a Beta of 0.94, which implies possible diversification benefits within a given portfolio. Relief Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Relief Therapeutics is expected to follow. Use Relief Therapeutics value at risk, as well as the relationship between the kurtosis and market facilitation index , to analyze future returns on Relief Therapeutics.
Auto-correlation | -0.5 |
Modest reverse predictability
Relief Therapeutics Holding has modest reverse predictability. Overlapping area represents the amount of predictability between Relief Therapeutics time series from 20th of November 2024 to 5th of December 2024 and 5th of December 2024 to 20th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Relief Therapeutics price movement. The serial correlation of -0.5 indicates that about 50.0% of current Relief Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Relief Therapeutics lagged returns against current returns
Autocorrelation, which is Relief Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Relief Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Relief Therapeutics returns to help us make a trade decision. For example, suppose you find that Relief Therapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Relief Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Relief Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Relief Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Relief Therapeutics otc stock over time.
Current vs Lagged Prices |
| Timeline |
Relief Therapeutics Lagged Returns
When evaluating Relief Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Relief Therapeutics otc stock have on its future price. Relief Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Relief Therapeutics autocorrelation shows the relationship between Relief Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Relief Therapeutics Holding.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Relief OTC Stock Analysis
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.